USE OF DIMER-SPECIFIC NUCLEAR LOCALISATION SIGNAL PEPTIDES (DSNLS) DERIVED FROM THE STAT DNA BINDING DOMAIN

摘要

The invention relates to the use of dimer-specific nuclear localisation signal peptides (dsNLS) derived from the STAT DNA binding domain for the diagnosis and/or treatment of diseases related to said peptides, and as target molecules for screening pharmacological active ingredients.